HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
Home » News » 6 Recommendations Regarding HTAs in the United States

6 Recommendations Regarding HTAs in the United States

A whitepaper was recently released by researchers at the USC Schaeffer Center and the Aspen Institute. The authors discuss half a dozen recommendations relating to HTAs (Health Technology Assessments) in the United States, which could lead to changes in the pricing of prescription drugs. Implementing an HTA, similar to ICER (Institute for Clinical and Economic Review), could provide limit costs for patients and improve equity.

The authors note, “Health technology assessment (HTA) can help achieve the dual health policy goals of ensuring affordability and encouraging innovation. It represents a formal, systematic and transparent multidisciplinary process that uses explicit methods and available evidence to determine the value of a health technology. The dimensions of value most often include clinical effectiveness, safety, costs and economic implications and may include ethical, social, cultural and legal issues, organizational and environmental aspects, as well as wider implications for the patient, relatives, caregivers and population.” Read more here.

(Source: Lakdawalla et al., USC Schaeffer, 2/9/21)

You might be interested in:

  1. Tenacious Sheila McLean Joins Patients for Affordable Drugs
  2. 2021’s PBMI Conference Featured Lively Discussions on Specialty Drug Costs, Data Interoperability, and RWD
  3. Tracing the Health Care Experience Informs Decision-making
  4. Prescription Drug Pricing Reform Could Mean Discounts on AAP Drugs Pending Clinical Proof

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • RWE HEOR Manager
  • Associate Director/Director, RWE
  • Associate Director of HEOR Analytics
  • RWD Scientist - Oncology
  • Associate Director, Biostatistics
 
Syndicated Reports

Current and Future Analysis of Real World Data Market With New Business Strategies and Forecast by 2029 Parexel International Corporation, TriNetX LLC

Global Gene Therapy Report 2022-2031

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Economic & Related Consulting Service Revenues World Report & Database

 
White Papers

How Corporate Executives View Rising Health Care Cost and the Role of Government

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Build or Buy – Which Is the Right QMS Choice for Your Company?

Finland – A treasure trove for real-world evidence (RWE) research and innovation

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists